Sales Effectiveness and ROI

E-Detailing: Stimulating Food For Thought

Detailing is a long-standing way of pharmaceutical companies telling doctors about their drugs in a one-to-one sales call.

>> Click for more

Why pharmaceutical marketers must measure return on investment (ROI) to ensure profitable eDetailing campaigns

All types of pharmaceutical marketing should be subject to careful analysis of costs and financial return. eDetailing, although a relatively new marketing method, must not be treated differently from any other off- or online marketing activity and the return on investment (ROI) of an eDetailing programme is essential to ensure success.

>> Click for more

Navigating the eDetailing Maze

eDetailing is currently under consideration by many pharmaceutical companies as a way to maximise sales force time, cut costs and increase physician prescribing. eDetailing is not a single entity but can take many different forms: from remote live discussion with a sales rep to a purely scripted interaction with a web site or an Interactive Voice Response phone line.

>> Click for more

eDetailing in 2006 and Beyond

Colin Williams, e-Marketing Director at PharmiWeb Solutions takes a look at the current edetailing landscape and suggests what the future could hold for this much talked about tool for pharmaceutical marketing and sales departments.

>> Click for more

Improving Sales Force Effectiveness with Digital Technology Part 1: eLearning

Pharmaceutical companies depend on their sales force to build strong relationships with physicians. However, a Forrester report stated that traditional detailing has 'reached the end of its rope’. The report stated that doctors generally don’t trust sales reps and are increasingly not seeing them.

>> Click for more

Improving Sales Force Effectiveness with Digital Technology Part 2: eDetailing and its ROI

eDetailing is being discussed by the majority of pharmaceutical marketing and sales departments as a way to utilize sales force time more efficiently while saving costs and increasing sales.

>> Click for more

Marketing to Win Market Share - The Role of Doctor Sentiment and Benchmarking

Pharma marketing should and must give measurable return on investment (ROI) from marketing activities. This is not only possible but absolutely crucial in the current climate of decreasing margins and increased competition.

>> Click for more

Marketing ROI: The role of predictive mathematics

Do you really know which of your sales and marketing activities will increase or decrease your market share and by how much? Perhaps you think putting more sales reps on the road or eDetailing will do the trick. Maybe you believe increasing journal advertising, publicity and opinion leader programmes or jumping on the bandwagon of the next buzz initiative will have the desired effect. The fact is, implementing any, or all, of these activities will not necessarily improve your position.

>> Click for more

 

'The 7 Secrets
That Every Pharmaceutical Marketing Professional
Has To Know To Survive in 2008'

Download Free Report Here

* Email
* First Name
* Phone
* ROI Challenge
* = Required Field

Only company email addresses are accepted for this so if you use your hotmail, yahoo, gmail, aol, comcast etc. email addresses, they will be rejected.

Your email address will be 100% protected and will never, ever be shared.

What Our Clients Say

"Powerful stuff. In my 20 years of marketing I have never seen such valuable data."
Specialist Team Leader, Pfizer

It provides a level of insight which has been difficult to obtain using existing tools. The team were impressed by its ability to predict market share movements based on mix investment decisions.
Brand Manager, GSK

"The analytics from Eularis, in combination with their analytics products, have provided a foundation for many of our corporate performance metrics as well as our brand marketing ROI metrics."
Senior Vice President, Pfizer